Project Grant HT94252310734
Award Date
8/15/23
Completion Date
8/14/26
Dollars Obligated
$781K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
The Trustees of Boston University will receive $330,000 from the Defense Health Agency under a Project Grant award to identify receptors for TDP-43 that mediate cellular uptake and neurotoxicity. This research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health...
The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,704,652.00 to Trustees of Boston University (Boston University Medical Campus) to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness (GWI). The award period runs from September 1, 2024 to August...
The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...
The Defense Health Agency awarded Trustees of Dartmouth College a $2,031,453 project grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop machine learning strategies for predicting suicide risk using clinical note text from May 1, 2023 to April 30, 2026. Dartmouth College will utilize subawards to Cedars-Sinai Medical Center, Vanderbilt University Medical Center, and Veterans Education And Research Association Of Northern New England, Inc. to...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $713,277 to Boston University Medical Campus to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness. The award will support the project from September 1, 2024 through August 31, 2027. As part of this...
The Department of the Army Medical Command awarded Boston University $999,636 under the Military Medical Research and Development federal grant program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The award will support the identification of objective brain imaging biomarkers for Gulf War Illness through exposure- and symptom-specific markers, Gulf War illness subtypes, and longitudinal patterns. Dr. Steele of Baylor College of Medicine will collaborate with Boston University researchers on...